Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Buy
62
IMCC Quote, Financials, Valuation and Earnings
Last price:
$1.80
Seasonality move
:
-16.2%
Day range:
$1.67 - $1.84
52-week range:
$0.93 - $7.12
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.17x
P/B ratio:
3.83x
Volume:
38.5K
Avg. volume:
917.9K
1-year change:
-37.53%
Market cap:
$10.9M
Revenue:
$39.4M
EPS (TTM):
-$0.79
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$10.3M | -- | 31.7% | -- | -- |
|
IDTA
Identa Corp.
|
-- | -- | -- | -- | -- |
|
IRME
IR-Med, Inc.
|
-- | -- | -- | -- | -- |
|
PHGE
BiomX, Inc.
|
-- | -$6.08 | -- | -206.85% | $399.00 |
|
PLUR
Pluri, Inc.
|
$638K | -$0.74 | 316.67% | -79.86% | $12.00 |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$1.79 | -- | $10.9M | -- | $0.00 | 0% | 0.17x |
|
IDTA
Identa Corp.
|
$0.17 | -- | $688.6K | 7.51x | $0.00 | 0% | 0.59x |
|
IRME
IR-Med, Inc.
|
$0.05 | -- | $3.6M | -- | $0.00 | 0% | -- |
|
PHGE
BiomX, Inc.
|
$4.51 | $399.00 | $6.9M | -- | $0.00 | 0% | -- |
|
PLUR
Pluri, Inc.
|
$3.42 | $12.00 | $31.6M | -- | $0.00 | 0% | 18.70x |
|
RAPH
Raphael Pharmaceutical, Inc.
|
$1.00 | -- | $19.6M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
81.59% | 10.871 | 105.66% | 0.35x |
|
IDTA
Identa Corp.
|
37.84% | 0.503 | -- | 1.47x |
|
IRME
IR-Med, Inc.
|
-66.67% | 8.293 | 5.39% | 0.12x |
|
PHGE
BiomX, Inc.
|
38.57% | 0.072 | 20.14% | 1.51x |
|
PLUR
Pluri, Inc.
|
149.64% | 0.573 | 81% | 0.49x |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-3.35% | 7.252 | 0.52% | 0.00x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
IMCC
IM Cannabis Corp.
|
$2M | -$3M | -25.37% | -135.96% | -29.98% | -$3M |
|
IDTA
Identa Corp.
|
$194K | $100.8K | 2.33% | 42.57% | 23.58% | -$65K |
|
IRME
IR-Med, Inc.
|
-$4K | -$286K | -- | -- | -- | -$71K |
|
PHGE
BiomX, Inc.
|
-$1.2M | -$8.5M | -116.24% | -160.84% | -- | -$7.2M |
|
PLUR
Pluri, Inc.
|
-$15K | -$6.4M | -77.49% | -5662.45% | -2009.49% | -$5.5M |
|
RAPH
Raphael Pharmaceutical, Inc.
|
-- | -$251K | -- | -- | -- | -$17K |
IM Cannabis Corp. vs. Competitors
-
Which has Higher Returns IMCC or IDTA?
Identa Corp. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of 18.62%. IM Cannabis Corp.'s return on equity of -135.96% beat Identa Corp.'s return on equity of 42.57%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M IDTAIdenta Corp.45.38% -- $1.1M -
What do Analysts Say About IMCC or IDTA?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 234.82%. On the other hand Identa Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than Identa Corp., analysts believe IM Cannabis Corp. is more attractive than Identa Corp..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 IDTAIdenta Corp.0 0 0 -
Is IMCC or IDTA More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Identa Corp. has a beta of 0.669, suggesting its less volatile than the S&P 500 by 33.138%.
-
Which is a Better Dividend Stock IMCC or IDTA?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Identa Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Identa Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or IDTA?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Identa Corp. quarterly revenues of $427.5K. IM Cannabis Corp.'s net income of -$2.8M is lower than Identa Corp.'s net income of $79.6K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Identa Corp.'s PE ratio is 7.51x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.17x versus 0.59x for Identa Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.17x -- $10.1M -$2.8M IDTAIdenta Corp.0.59x 7.51x $427.5K $79.6K
-
Which has Higher Returns IMCC or IRME?
IR-Med, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of --. IM Cannabis Corp.'s return on equity of -135.96% beat IR-Med, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M IRMEIR-Med, Inc.-- -$0.01 -$375K -
What do Analysts Say About IMCC or IRME?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 234.82%. On the other hand IR-Med, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than IR-Med, Inc., analysts believe IM Cannabis Corp. is more attractive than IR-Med, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 IRMEIR-Med, Inc.0 0 0 -
Is IMCC or IRME More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison IR-Med, Inc. has a beta of 2.696, suggesting its more volatile than the S&P 500 by 169.614%.
-
Which is a Better Dividend Stock IMCC or IRME?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IR-Med, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. IR-Med, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or IRME?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than IR-Med, Inc. quarterly revenues of --. IM Cannabis Corp.'s net income of -$2.8M is lower than IR-Med, Inc.'s net income of -$701K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while IR-Med, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.17x versus -- for IR-Med, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.17x -- $10.1M -$2.8M IRMEIR-Med, Inc.-- -- -- -$701K
-
Which has Higher Returns IMCC or PHGE?
BiomX, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of --. IM Cannabis Corp.'s return on equity of -135.96% beat BiomX, Inc.'s return on equity of -160.84%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M PHGEBiomX, Inc.-- -$5.55 $17.1M -
What do Analysts Say About IMCC or PHGE?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 234.82%. On the other hand BiomX, Inc. has an analysts' consensus of $399.00 which suggests that it could grow by 8747.01%. Given that BiomX, Inc. has higher upside potential than IM Cannabis Corp., analysts believe BiomX, Inc. is more attractive than IM Cannabis Corp..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 PHGEBiomX, Inc.1 0 0 -
Is IMCC or PHGE More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison BiomX, Inc. has a beta of 1.558, suggesting its more volatile than the S&P 500 by 55.818%.
-
Which is a Better Dividend Stock IMCC or PHGE?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. BiomX, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. BiomX, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or PHGE?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than BiomX, Inc. quarterly revenues of --. IM Cannabis Corp.'s net income of -$2.8M is higher than BiomX, Inc.'s net income of -$9.2M. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while BiomX, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.17x versus -- for BiomX, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.17x -- $10.1M -$2.8M PHGEBiomX, Inc.-- -- -- -$9.2M
-
Which has Higher Returns IMCC or PLUR?
Pluri, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of -1940.51%. IM Cannabis Corp.'s return on equity of -135.96% beat Pluri, Inc.'s return on equity of -5662.45%.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M PLURPluri, Inc.-4.75% -$0.65 $28.6M -
What do Analysts Say About IMCC or PLUR?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 234.82%. On the other hand Pluri, Inc. has an analysts' consensus of $12.00 which suggests that it could grow by 250.88%. Given that Pluri, Inc. has higher upside potential than IM Cannabis Corp., analysts believe Pluri, Inc. is more attractive than IM Cannabis Corp..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 PLURPluri, Inc.1 0 0 -
Is IMCC or PLUR More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Pluri, Inc. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.476%.
-
Which is a Better Dividend Stock IMCC or PLUR?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Pluri, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Pluri, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or PLUR?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Pluri, Inc. quarterly revenues of $316K. IM Cannabis Corp.'s net income of -$2.8M is higher than Pluri, Inc.'s net income of -$6.1M. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Pluri, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.17x versus 18.70x for Pluri, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.17x -- $10.1M -$2.8M PLURPluri, Inc.18.70x -- $316K -$6.1M
-
Which has Higher Returns IMCC or RAPH?
Raphael Pharmaceutical, Inc. has a net margin of -27.9% compared to IM Cannabis Corp.'s net margin of --. IM Cannabis Corp.'s return on equity of -135.96% beat Raphael Pharmaceutical, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital IMCCIM Cannabis Corp.19.72% -$0.55 $15.7M RAPHRaphael Pharmaceutical, Inc.-- -$0.01 -$1.2M -
What do Analysts Say About IMCC or RAPH?
IM Cannabis Corp. has a consensus price target of --, signalling upside risk potential of 234.82%. On the other hand Raphael Pharmaceutical, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that IM Cannabis Corp. has higher upside potential than Raphael Pharmaceutical, Inc., analysts believe IM Cannabis Corp. is more attractive than Raphael Pharmaceutical, Inc..
Company Buy Ratings Hold Ratings Sell Ratings IMCCIM Cannabis Corp.0 0 0 RAPHRaphael Pharmaceutical, Inc.0 0 0 -
Is IMCC or RAPH More Risky?
IM Cannabis Corp. has a beta of 2.180, which suggesting that the stock is 117.961% more volatile than S&P 500. In comparison Raphael Pharmaceutical, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock IMCC or RAPH?
IM Cannabis Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Raphael Pharmaceutical, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. IM Cannabis Corp. pays -- of its earnings as a dividend. Raphael Pharmaceutical, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios IMCC or RAPH?
IM Cannabis Corp. quarterly revenues are $10.1M, which are larger than Raphael Pharmaceutical, Inc. quarterly revenues of --. IM Cannabis Corp.'s net income of -$2.8M is lower than Raphael Pharmaceutical, Inc.'s net income of -$255K. Notably, IM Cannabis Corp.'s price-to-earnings ratio is -- while Raphael Pharmaceutical, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for IM Cannabis Corp. is 0.17x versus -- for Raphael Pharmaceutical, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income IMCCIM Cannabis Corp.0.17x -- $10.1M -$2.8M RAPHRaphael Pharmaceutical, Inc.-- -- -- -$255K
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Google Vs NVIDIA Stock: Which Is Best?
Alphabet (NASDAQ:GOOGL) and NVIDIA (NASDAQ:NVIDIA) are two of the market’s…
How High Could NVIDIA Stock Go?
NVIDIA (NASDAQ:NVDA) has been one of the best stocks to…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 61x
Buy
61
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 38x
Buy
63
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 40x
Alerts
Sell
39
PSTG alert for Dec 5
Pure Storage, Inc. [PSTG] is up 5.05% over the past day.
Sell
15
HOV alert for Dec 5
Hovnanian Enterprises, Inc. [HOV] is down 22.58% over the past day.
Buy
69
ASTS alert for Dec 5
AST Spacemobile, Inc. [ASTS] is up 18.25% over the past day.
